Biomedical Engineering Lab
The Lee’s research group focuses on the three research areas including 1) Biosensor and in vitro diagnostic device development, 2) Nucleic acid nanoengineering-based therapy, and 3) Biomolecular-based bioelectronics for computation
Biosensor and In vitro diagnostic device Development
Imperative utilization of biosensors has acquired paramount importance in the field of drug discovery, biomedicine, food safety standards, defense, security, and environmental monitoring. This has led to the invention of precise and powerful analytical tools using bioprobe, nanomaterial and delicate electrode. BMEL are working on the development of cutting-edge biosensors and IVDs.
Nucleic acid nanoengineering-based therapy
One of the advantages of nanotechnology is the feasibility to construct therapeutic particles carrying multiple therapeutics with defined structure and stoichiometry. The field of nucleic acid nanoengineering is emerging. The newly-designed nucleic acid hybrid material could open the new horizons in the fabrication of therapeutic agents.
Biomolecular-based bioelectronics for computation
With all the progress that humankind has made to date in the development of delicate machinery and computing capabilities, understanding and communicating with living systems on that level of complexity lags behind. A breakthrough in these capabilities could only come if a way is found to integrate biological components into artificial devices. Herein, BMEL is trying to find out the fundamental concept of biocomputation systems.